jump to navigation

Philips Healthcare acquires CDP Medical to expand its clinical informatics portfolio August 5, 2010

Posted by israelhealthcare in Cardiology, clinical informatics, Electronic Patient Record.
Tags: ,
add a comment

Philips Healthcare has acquired the provider of Picture Archiving and Communication Systems (PACS) and CD distribution systems, CDP Medical, a subsidiary of medical device distributor Medtechnica. This acquisition demonstrates Philips’ continuing efforts to expand its offering in clinical informatics, and follows the recent acquisition of healthcare information system provider Tecso Informatica in Brazil.

PACS enable medical images to be stored electronically and viewed on doctor and clinician workstations in and outside hospitals, creating more efficient workflow and improved clinical results. PACS serves an increasingly crucial role in today’s healthcare environment as the need to streamline workflow and manage costs, all while providing high-quality care.

“This is an important step on our journey to complete our range of clinical informatics and patient care solutions that simplify clinician workflow, improve financial outcomes for our customer and help improve and save lives,” said Steve Rusckowski, CEO for Philips Healthcare. “The acquisition of the CDP business complements our current iSite PACS offering and allows us to better tap into certain high-growth market segments, geographically.”

Philips iSite PACS is an innovative image and information management system that delivers on-demand diagnostic-quality images over existing hospital networks, advanced radiology reading stations for radiologists, and long-term storage.

Philips' iSite PACS

Founded in 2000, CDP Medical has close to 300 hospital and clinic installations globally, with growth in the last year particularly coming from the Latin America region. The company is headquartered in Petah Tikva and has 20 employees.

Sponsored Links – Application Test Management Software | Epilepsy Alert System | Personal Home ECG/EKG Monitoring Device

Cardiac output monitoring technology developer Cheetah Medical raises $20 million March 16, 2010

Posted by israelhealthcare in Cardiology.
Tags: , , , , , , ,
1 comment so far

Noninvasive hemodynamic and cardiac output monitoring technology developer Cheetah Medical has raised $20 million in a second financing round. The investment round was led by Ascension Health Ventures (AHV) and also included Robert Bosch Venture Capital (RBVC), the investment arm of Bosch Group, MVM Life Science Partners and existing investors.

Cheetah Medical’s NICOM products provides a simple to use platform that enables physicians and nurses to quickly obtain accurate advanced hemodynamic parameters at the bedside, thereby aiding in differential diagnosis and selection and titration of the appropriate therapy to individualize patient care. Legacy approaches that rely on invasive, costly catheters have more limited use due to concerns about cost, maintenance requirements, invasiveness and potential complications.

“Because of its accuracy and non-invasiveness, Cheetah’s NICOM platform has the potential to significantly expand the hemodynamic monitoring market,” said Dr. Walter Lin, an Investment Manager with AHV. “The company validated technology can both improve outcomes and reduce the cost of care in what is generally a high acuity patient population.”

“By providing accurate, noninvasive, continuous hemodynamic information, NICOM can improve patient outcomes by helping clinicians optimize fluid and vasoactive drug management in areas such as critical care, anesthesia, emergency medicine and heart failure,” explain Yoav Avidor, CEO of Cheetah Medical.

Cheetah Medical’s NICOM noninvasive cardiac output and hemodynamic monitoring system uses the company’s proprietary BIOREACTANCE technology to deliver continuous, accurate, noninvasive cardiac output and other vital hemodynamic monitoring parameters. The system is US FDA cleared and CE Marked, and since its commercial launch in 2008 has been adopted by a growing number of clinicians worldwide.

Cheetah Medical headquarters is located in Tel-Aviv, Israel and its United States headquarters is located in Portland, Oregon.

Sponsored Links – Mobile Health Systems | Compression Therapy Devices

Medtronic acquires heart valve startup Ventor Technologies for $325 million February 24, 2009

Posted by israelhealthcare in Cardiology.
Tags: , ,
add a comment

American medical technology firm Medtronic has acquired Israeli startup Ventor Technologies, a developer of transcatheter heart valve technologies for the treatment of aortic valve disease, for $325 million.

Ventor developed a unique aortic valve prosthesis which can be implanted “off pump”, on a beating heart. Ventor’s unique valve design allows for easy implantation, enhanced prosthesis anchoring and superior hemodynamic performance.

Current standard of care for patients with aortic stenosis is open-heart valve surgery, however, many patients are ineligible for surgery because of their deteriorating health. Transcatheter valves offer a non-surgical alternative for patients who need their valve replaced but may not be good surgical candidates.

This deal will add two technologies to Medtronic’s transcatheter valve portfolio: a minimally invasive, surgical transapical technology and a next generation percutaneous, transfemoral technology. These complementary technologies offer compelling clinical benefit to distinctly different subsets of patients with aortic stenosis who are at high or prohibitive risk for surgery.

“The combination of Ventor Technologies and our strengths in research and development, operations, medical education and market development will improve patient outcomes and expand physician adoption among both surgeons and interventional cardiologists,” said Bill Hawkins, chairman and CEO of Medtronic.

Ventor was founded in 2004 by Dr. Ehud Shvemental of Sheba Medical Center Tel Hashomer, Rafi Benary, and Dr. Shimon Eckhouse, the co-founder of Syneron Medical. Guy Ezekiel is the current president and CEO of Ventor Technologies.

Medtronic is the global leader in medical technology with six major businesses focusing around a condition or therapy type: Cardiac Rhythm Disease Management, Spinal and Biologics, CardioVascular, Neuromodulation, Diabetes, and Surgical Technologies.

Sponsored Links – Brain Training Exercises | Home Personal Safety Solutions